Lanean...
Regarding “TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World”
This letter to the editor, regarding the reported results of the TELEPRO study by Strosberg et al., provides real‐world support of the benefit of telotristat ethyl for symptoms of carcinoid syndrome.
Gorde:
| Argitaratua izan da: | Oncologist |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356703/ https://ncbi.nlm.nih.gov/pubmed/32420675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0158 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|